Drug Screening Market Research Report Information By Product and Service (Drug Screening, Analytical Instruments, Rapid Testing Devices, Consumables, Drug Screening Service), By Sample Type (Urine Samples, Breath Samples, Oral Fluid Samples, Hair Samples, Other Samples), By End User (Drug Testing Laboratories, Criminal Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges, Workplaces) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World)

Global Drug Screening Market Overview

Drug Screening Market Size was valued at USD 5.5 Billion in 2022. The Drug Screening market industry is projected to grow from USD 6.4 Billion in 2023 to USD 22.9 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 17.20% during the forecast period (2024 - 2032). Increasing workplace rules for workers and growing problems with substance abuse are the key market drivers boosting the expansion of the market.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Drug Screening Market Trends

• Growing substance abuse concerns is driving the market growth

Market CAGR for Drug Screening is being driven by the rising number of abuse concerns. Drug screening assists in determining whether drugs or the products of their metabolism are present in a person's biological material, which is typically their blood, saliva, urine, or hair. Drug testing is frequently used by employers, healthcare professionals, and law enforcement agencies to assess drug use or abuse. This preventive action helps identify possible health risks, maintain workplace security, and comply with requirements.

Additionally, regular drug testing is required by strict workplace standards and employment legislation, especially in sectors where safety is a priority, like construction, transportation, and healthcare. Drug testing systems must be implemented by employers in order to comply with regulatory obligations, maintain a safe workplace, and reduce potential liabilities. This driver emphasizes how important drug testing is to preserving employee wellbeing, workplace safety, and adherence to industry-specific regulations. Testing methods are expected to undergo considerable technological developments as a result of the drug screening market's growth. The creation of testing kits that are more precise and sensitive, speedier and non-invasive screening techniques and the use of cutting-edge technologies like nanotechnology or biosensors are a few examples of innovations. These developments add to a wider variety of compounds that can be detected and improve the precision and effectiveness of drug screening.

Strong drug screening policies are becoming more and more necessary as substance misuse issues, such as the upload crisis, become more widespread. In order to lessen the negative effects of substance abuse on people's health and the general well-being of society, industries and healthcare institutions must quickly detect and treat substance addiction. Drug screening is positioned as a critical tool in early diagnosis, intervention, and prevention due to the pressing need to address substance abuse-related concerns. This aligns with broader public health objectives and regulatory imperatives. The growth of drug testing programs may encourage a change in focus to preventive healthcare programs. Frequent and extensive screening for substance addiction could develop into a proactive strategy to spot and handle any possible health risks linked to drug use.

For instance, the World Drug Report 2021 states that 36.3 million individuals worldwide, or over 13% of the world's population, were predicted to suffer from drug use problems in 2019. Substance abuse problems caused the loss of 18 million years of healthy living, mainly from opioids, and drug use killed close to half a million individuals in a single year. Many strict laws are in place to reduce drug use. Which will increase from USD 6.22 billion in 2022 to USD 22.28 billion by 2030, demand for Drug Screening supplements will increase due to the rising Abuse Concerns. Thus, result in driving the Drug Screening market revenue.

Drug Screening Market Segment Insights

Drug Screening Product and Service Insights

The Drug Screening Market segmentation, based on Product and Service includes Drug screening, Analytical Instruments, Rapid Testing Devices, Consumables, Drug Screening Service. The consumables segment dominated the market. This is because growing more quickly now that more sophisticated consumables are being released, offering better ways to make testing quick, accurate, and simple. These calibrators and controls carry out validation testing for labs to do away with step measurement and oversee controls and certifications, materials acquisition and setup, and repeated handling.

Drug Screening Sample Type Insights

The Drug Screening Market segmentation, based on Sample Type, includes Urine samples, Breath Samples, Oral Fluid Samples, Hair Samples, and Other Samples. The urine samples generated the most income. Because the most used sample type for detecting the presence of illegal substances is urine. On the other hand, adulteration of urine samples is increasingly frequent in order to generate a false-negative test result, which can hinder market expansion.

Figure1: Drug Screening Market, by Sample Type, 2022&2032 (USD Billion)

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Drug Screening End User Insights

The Drug Screening Market segmentation, based on End User, includes Drug Testing Laboratories, Criminal Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges, Workplaces. The Drug Testing Laboratories generated the most income. Because drug testing facilities are able to detect the presence of illicit substances, rapid tests are unable to do so. Other benefits of drug testing labs are the availability of advanced instruments, such spectroscopy and HPLC, and skilled staff that can perform tests with accurate findings.

Drug Screening Regional Insights

By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North American Drug Screening market area will dominate this market, owing to an a number of factors, including strict restrictions for occupational testing and the presence of significant firms executing aggressive expansion initiatives will boost market growth in this region.

Further, the major countries studied in the market report are The US, German, France, the UK, Canada, Italy, Spain, India, Australia, South Korea, China, Japan, and Brazil.

Figure2: DRUG SCREENING MARKET SHARE BY REGION 2022 (USD Billion)

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Europe Drug Screening market has the second-largest portion of the market due to the expanding usage of random drug tests and substance abuse screening in pre-employment to guarantee drug-free workplaces. Further, the German Drug Screening market had the biggest market share, and the UK Drug Screening market was the fastest increasing market in the European region

The Asia-Pacific Drug Screening Market is anticipated to expand between 2023 and 2032 at the quickest CAGR. This is due to rise in drug-related crimes, substance misuse disorders, and deadly car accidents. Moreover, China’s Drug Screening market had the biggest market share, and the Indian Drug Screening market was the fastest increasing market in the Asia-Pacific region.

Drug Screening Key Market Players & Competitive Insights

Leading market players are putting a lot of money on R&D to expand their product lines, which will help the market for weight reduction products grow. Additionally, market players are engaging in a range of calculated initiatives to increase their worldwide presence, with important market developments involving the introduction of new products, contracts, M&A transactions, increased investment, and cooperation with other enterprises. to grow and endure in an increasingly cutthroat and dynamic market, Drug Screening industry must provide reasonably priced goods.

Manufacturing locally is one of the primary business techniques used by manufacturers to cut operational costs in the global Drug Screening industry to help customers and expand the market segment. In recent years, the Drug Screening industry has provided some of the biggest benefits to medicine. Major players in the Drug Screening market, including LabCorp (US), Quest Diagnostics (US), Abbott Laboratories (US), OraSure Technologies (US), Alfa Scientific Designs (US), and others, are attempting to increase market demand by investing in research and development operations.

The American healthcare corporation Laboratory Corporation of America Holdings, or Labcorp for short is based in Burlington, North Carolina. It runs one of the biggest clinical laboratory networks globally, comprising 36 primary laboratories across the United States. The business was known as Roche BioMedical until it merged with National Health Laboratory in 1995. The Center for Esoteric Testing at Labcorp in Burlington is where the company conducts the majority of its specialist testing.In September 2020, LabCorp and Infirmary Health (US) established a multi-year contract for LabCorp to provide laboratory testing services along the eastern Gulf Coast.

Quest Diagnostics is a clinical laboratory located in America. Operating in the US, Puerto Rico, Mexico, and Brazil, Quest is a Fortune 500 firm. Additionally, Quest has cooperative agreements in place with a number of clinics and hospitals worldwide. The corporation employed about 48,000 people as of 2020, and in 2019 it brought in more than $7.7 billion. The business provides access to cancer diagnostic testing services. In August 2021, Quest Diagnostics and Select Health of South Carolina signed a contract to improve member access to diagnostic information services and to grow Select Health's laboratory network for its Medicaid and Medicare-Medicaid dual-eligible enrollees.

Key Companies in the Drug Screening market include

• LabCorp (US)


• Quest Diagnostics (US)


• Abbott Laboratories (US)


• OraSure Technologies (US)


• Alfa Scientific Designs (US)


• Thermeisher Scientific (US)


• Drägerwerk (Germany)


• LifeLoc (US)


• MPD Inc. (US)


• Omega Laboratories (US)


• Premier Biotech (US)


• Psychemedics (US)


• Roche (Switzerland)


• Shimadzu (Japan)


• Siemens Healthineers (Germany)

Drug Screening Industry Developments

August 2021: Quest Diagnostics and Select Health of South Carolina have come to an agreement to enhance members' access to diagnostic information services and to grow Select Health's laboratory network for Medicaid and Medicare-Medicaid dual-eligible enrollees.

May 2020: A Vaping Panel was introduced by Psychemedics Corporation to identify the usage of CBD, nicotine, and marijuana. This test gives educational institutions and commercial establishments a mechanism to identify drug consumption through any means, like using electronic cigarettes or smoking.

April 1019: The CEDIA Mitragynine (Kratom) Assay was introduced by Thermo Fisher Scientific for use in forensics and criminal justice. Several notable entities in the worldwide drug testing industry comprise.

Drug Screening Market Segmentation

Drug Screening Product and Service Outlook

• Drug screening


• Analytical Instruments


• Rapid Testing Devices


• Consumables


• Drug Screening Service

Drug Screening Sample Type Outlook

• Urine samples


• Breath Samples


• Oral Fluid Samples


• Hair Samples


• Other Samples

Drug Screening End User Outlook

• Drug Testing Laboratories


• Criminal Justice and Law Enforcement Agencies


• Hospitals


• Drug Treatment Centers


• Individual Users


• Pain Management Centers


• Schools and Colleges


• Workplaces

Drug Screening Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America